Norwegian University Of Science And Technolology

The medical center is at the forefront of research into Latent Autoimmune Diabetes in Adults (LADA), focusing on innovative treatment approaches. The center's work in this area is characterized by its exploration of the long-term effects of GAD-alum treatment, particularly in relation to genetic markers such as HLA-DR3DQ2.

• Beta cell function assessment
• Metabolic control evaluation
• Genetic marker analysis

By investigating the impact of genetic predispositions on treatment outcomes, the center contributes significantly to personalized medicine in diabetes care.

Specializing in the treatment of chronic cluster headache, the center is pioneering the use of botulinum toxin targeting the sphenopalatine ganglion (SPG). This innovative approach utilizes advanced image-guided surgical technology to enhance precision and efficacy.

• Refractory headache treatment
• Image-guided surgical techniques
• Botulinum toxin applications

The center's research in this field aims to provide relief for patients with limited treatment options, advancing the understanding and management of chronic pain conditions.